Skip to main content
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1996 Jan;9(1):72–99. doi: 10.1128/cmr.9.1.72

Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease.

H B Urnovitz 1, W H Murphy 1
PMCID: PMC172883  PMID: 8665478

Abstract

Retroviral diagnostics have become standard in human laboratory medicine. While current emphasis is placed on the human exogenous viruses (human immunodeficiency virus and human T-cell leukemia virus), evidence implicating human endogenous retroviruses (HERVs) in various human disease entities continues to mount. Literature on the occurrence of HERVs in human tissues and cells was analyzed. Substantial evidence documents that retrovirus particles were clearly demonstrable in various tissues and cells in both health and disease and were abundant in the placenta and that their occurrence could be implicated in some of the reproductive diseases. The characteristics of HERVs are summarized, mechanisms of replication and regulation are outlined, and the consistent hormonal responsiveness of HERVs is noted. Clear evidence implicating HERV gene products as participants in glomerulonephritis in some cases of systemic lupus erythematosus is adduced. Data implicating HERVs as etiologic factors in reproductive diseases, in some of the autoimmune diseases, in some forms of rheumatoid arthritis and connective tissue disease, in psoriasis, and in some of the inflammatory neurologic diseases are reviewed. The current major needs are to improve methods for HERV detection, to identify the most appropriate HERV prototypes, and to develop diagnostic reagents so that the putative biologic and pathologic roles of HERVs can be better evaluated.

Full Text

The Full Text of this article is available as a PDF (474.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham G. N., Khan A. S. Human endogenous retroviruses and immune disease. Clin Immunol Immunopathol. 1990 Jul;56(1):1–8. doi: 10.1016/0090-1229(90)90163-k. [DOI] [PubMed] [Google Scholar]
  2. Acha-Orbea H. Retroviral superantigens. Chem Immunol. 1992;55:65–86. [PubMed] [Google Scholar]
  3. Arima N., Molitor J. A., Smith M. R., Kim J. H., Daitoku Y., Greene W. C. Human T-cell leukemia virus type I Tax induces expression of the Rel-related family of kappa B enhancer-binding proteins: evidence for a pretranslational component of regulation. J Virol. 1991 Dec;65(12):6892–6899. doi: 10.1128/jvi.65.12.6892-6899.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BERNHARD W. Electron microscopy of tumor cells and tumor viruses; a review. Cancer Res. 1958 Jun;18(5):491–509. [PubMed] [Google Scholar]
  5. Ballard D. W., Böhnlein E., Lowenthal J. W., Wano Y., Franza B. R., Greene W. C. HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene. Science. 1988 Sep 23;241(4873):1652–1655. doi: 10.1126/science.241.4873.1652. [DOI] [PubMed] [Google Scholar]
  6. Bandziulis R. J., Swanson M. S., Dreyfuss G. RNA-binding proteins as developmental regulators. Genes Dev. 1989 Apr;3(4):431–437. doi: 10.1101/gad.3.4.431. [DOI] [PubMed] [Google Scholar]
  7. Banki K., Maceda J., Hurley E., Ablonczy E., Mattson D. H., Szegedy L., Hung C., Perl A. Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: a possible autoantigen for HTLV-I gag-reactive autoantibodies. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1939–1943. doi: 10.1073/pnas.89.5.1939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Barbacid M., Bolognesi D., Aaronson S. A. Humans have antibodies capable of recognizing oncoviral glycoproteins: demonstration that these antibodies are formed in response to cellular modification of glycoproteins rather than as consequence of exposure to virus. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1617–1621. doi: 10.1073/pnas.77.3.1617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Barry P. A., Pratt-Lowe E., Peterlin B. M., Luciw P. A. Cytomegalovirus activates transcription directed by the long terminal repeat of human immunodeficiency virus type 1. J Virol. 1990 Jun;64(6):2932–2940. doi: 10.1128/jvi.64.6.2932-2940.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Beato M. Gene regulation by steroid hormones. Cell. 1989 Feb 10;56(3):335–344. doi: 10.1016/0092-8674(89)90237-7. [DOI] [PubMed] [Google Scholar]
  11. Bermas B. L., Petri M., Berzofsky J. A., Waisman A., Shearer G. M., Mozes E. Binding of glycoprotein 120 and peptides from the HIV-1 envelope by autoantibodies in mice with experimentally induced systemic lupus erythematosus and in patients with the disease. AIDS Res Hum Retroviruses. 1994 Sep;10(9):1071–1077. doi: 10.1089/aid.1994.10.1071. [DOI] [PubMed] [Google Scholar]
  12. Beutner U., Frankel W. N., Cote M. S., Coffin J. M., Huber B. T. Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5432–5436. doi: 10.1073/pnas.89.12.5432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Blomberg J., Nived O., Pipkorn R., Bengtsson A., Erlinge D., Sturfelt G. Increased antiretroviral antibody reactivity in sera from a defined population of patients with systemic lupus erythematosus. Correlation with autoantibodies and clinical manifestations. Arthritis Rheum. 1994 Jan;37(1):57–66. doi: 10.1002/art.1780370109. [DOI] [PubMed] [Google Scholar]
  14. Boller K., König H., Sauter M., Mueller-Lantzsch N., Löwer R., Löwer J., Kurth R. Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDV. Virology. 1993 Sep;196(1):349–353. doi: 10.1006/viro.1993.1487. [DOI] [PubMed] [Google Scholar]
  15. Bonner T. I., O'Connell C., Cohen M. Cloned endogenous retroviral sequences from human DNA. Proc Natl Acad Sci U S A. 1982 Aug;79(15):4709–4713. doi: 10.1073/pnas.79.15.4709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Boyd M. T., Bax C. M., Bax B. E., Bloxam D. L., Weiss R. A. The human endogenous retrovirus ERV-3 is upregulated in differentiating placental trophoblast cells. Virology. 1993 Oct;196(2):905–909. doi: 10.1006/viro.1993.1556. [DOI] [PubMed] [Google Scholar]
  17. Boyd M. T., Maclean N., Oscier D. G. Detection of retrovirus in patients with myeloproliferative disease. Lancet. 1989 Apr 15;1(8642):814–817. doi: 10.1016/s0140-6736(89)92273-3. [DOI] [PubMed] [Google Scholar]
  18. Brodsky I., Foley B., Haines D., Johnston J., Cuddy K., Gillespie D. Expression of HERV-K proviruses in human leukocytes. Blood. 1993 May 1;81(9):2369–2374. [PubMed] [Google Scholar]
  19. Bronson D. L., Ritzi D. M., Fraley E. E., Dalton A. J. Morphologic evidence for retrovirus production by epithelial cells derived from a human testicular tumor metastasis. J Natl Cancer Inst. 1978 Jun;60(6):1305–1308. doi: 10.1093/jnci/60.6.1305. [DOI] [PubMed] [Google Scholar]
  20. Bronson D. L., Saxinger W. C., Ritzi D. M., Fraley E. E. Production of virions with retrovirus morphology by human embryonal carcinoma cells in vitro. J Gen Virol. 1984 Jun;65(Pt 6):1043–1051. doi: 10.1099/0022-1317-65-6-1043. [DOI] [PubMed] [Google Scholar]
  21. Callahan R., Chiu I. M., Wong J. F., Tronick S. R., Roe B. A., Aaronson S. A., Schlom J. A new class of endogenous human retroviral genomes. Science. 1985 Jun 7;228(4704):1208–1211. doi: 10.1126/science.2408338. [DOI] [PubMed] [Google Scholar]
  22. Canaani E., Dreazen O., Klar A., Rechavi G., Ram D., Cohen J. B., Givol D. Activation of the c-mos oncogene in a mouse plasmacytoma by insertion of an endogenous intracisternal A-particle genome. Proc Natl Acad Sci U S A. 1983 Dec;80(23):7118–7122. doi: 10.1073/pnas.80.23.7118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Celander D., Hsu B. L., Haseltine W. A. Regulatory elements within the murine leukemia virus enhancer regions mediate glucocorticoid responsiveness. J Virol. 1988 Apr;62(4):1314–1322. doi: 10.1128/jvi.62.4.1314-1322.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Chang D. D., Sharp P. A. Messenger RNA transport and HIV rev regulation. Science. 1990 Aug 10;249(4969):614–615. doi: 10.1126/science.2143313. [DOI] [PubMed] [Google Scholar]
  25. Chiu I. M., Callahan R., Tronick S. R., Schlom J., Aaronson S. A. Major pol gene progenitors in the evolution of oncoviruses. Science. 1984 Jan 27;223(4634):364–370. doi: 10.1126/science.6197754. [DOI] [PubMed] [Google Scholar]
  26. Cianciolo G. J., Copeland T. D., Oroszlan S., Snyderman R. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science. 1985 Oct 25;230(4724):453–455. doi: 10.1126/science.2996136. [DOI] [PubMed] [Google Scholar]
  27. Clerici M., Lucey D. R., Berzofsky J. A., Pinto L. A., Wynn T. A., Blatt S. P., Dolan M. J., Hendrix C. W., Wolf S. F., Shearer G. M. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science. 1993 Dec 10;262(5140):1721–1724. doi: 10.1126/science.7903123. [DOI] [PubMed] [Google Scholar]
  28. Clerici M., Shearer G. M. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today. 1994 Dec;15(12):575–581. doi: 10.1016/0167-5699(94)90220-8. [DOI] [PubMed] [Google Scholar]
  29. Cohen M., Kato N., Larsson E. ERV3 human endogenous provirus mRNAs are expressed in normal and malignant tissues and cells, but not in choriocarcinoma tumor cells. J Cell Biochem. 1988 Feb;36(2):121–128. doi: 10.1002/jcb.240360203. [DOI] [PubMed] [Google Scholar]
  30. Contag C. H., Plagemann P. G. Age-dependent poliomyelitis of mice: expression of endogenous retrovirus correlates with cytocidal replication of lactate dehydrogenase-elevating virus in motor neurons. J Virol. 1989 Oct;63(10):4362–4369. doi: 10.1128/jvi.63.10.4362-4369.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Copeland N. G., Hutchison K. W., Jenkins N. A. Excision of the DBA ecotropic provirus in dilute coat-color revertants of mice occurs by homologous recombination involving the viral LTRs. Cell. 1983 Jun;33(2):379–387. doi: 10.1016/0092-8674(83)90419-1. [DOI] [PubMed] [Google Scholar]
  32. Crabtree G. R. Contingent genetic regulatory events in T lymphocyte activation. Science. 1989 Jan 20;243(4889):355–361. doi: 10.1126/science.2783497. [DOI] [PubMed] [Google Scholar]
  33. Cullen B. R. Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol Rev. 1992 Sep;56(3):375–394. doi: 10.1128/mr.56.3.375-394.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Dalton A. J. Further analysis of the detailed structure of type B and C particles. J Natl Cancer Inst. 1972 Apr;48(4):1095–1099. [PubMed] [Google Scholar]
  35. DeFreitas E., Hilliard B., Cheney P. R., Bell D. S., Kiggundu E., Sankey D., Wroblewska Z., Palladino M., Woodward J. P., Koprowski H. Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2922–2926. doi: 10.1073/pnas.88.7.2922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Deen K. C., Sweet R. W. Murine mammary tumor virus pol-related sequences in human DNA: characterization and sequence comparison with the complete murine mammary tumor virus pol gene. J Virol. 1986 Feb;57(2):422–432. doi: 10.1128/jvi.57.2.422-432.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Deragon J. M., Sinnett D., Labuda D. Reverse transcriptase activity from human embryonal carcinoma cells NTera2D1. EMBO J. 1990 Oct;9(10):3363–3368. doi: 10.1002/j.1460-2075.1990.tb07537.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Derks J. P., Hofmans L., Bruning H. W., von Rood J. J. Synthesis of a viral protein with molecular weight of 30,000 (p30) by leukemic cells and antibodies cross-reacting with Simian sarcoma virus p30 in serum of a chronic myeloid leukemia patient. Cancer Res. 1982 Feb;42(2):681–686. [PubMed] [Google Scholar]
  39. Dirksen E. R., Levy J. A. Virus-like particles in placentas from normal individuals and patients with systemic lupus erythematosus. J Natl Cancer Inst. 1977 Oct;59(4):1187–1192. doi: 10.1093/jnci/59.4.1187. [DOI] [PubMed] [Google Scholar]
  40. Doolittle R. F., Feng D. F., Johnson M. S., McClure M. A. Origins and evolutionary relationships of retroviruses. Q Rev Biol. 1989 Mar;64(1):1–30. doi: 10.1086/416128. [DOI] [PubMed] [Google Scholar]
  41. Dornburg R., Temin H. M. Presence of a retroviral encapsidation sequence in nonretroviral RNA increases the efficiency of formation of cDNA genes. J Virol. 1990 Feb;64(2):886–889. doi: 10.1128/jvi.64.2.886-889.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Dougherty R. M., Di Stefano H. S. Virus particles associated with "nonproducer" Rous sarcoma cells. Virology. 1965 Nov;27(3):351–359. doi: 10.1016/0042-6822(65)90115-7. [DOI] [PubMed] [Google Scholar]
  43. Ensoli B., Barillari G., Salahuddin S. Z., Gallo R. C., Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature. 1990 May 3;345(6270):84–86. doi: 10.1038/345084a0. [DOI] [PubMed] [Google Scholar]
  44. Faff O., Murray A. B., Schmidt J., Leib-Mösch C., Erfle V., Hehlmann R. Retrovirus-like particles from the human T47D cell line are related to mouse mammary tumour virus and are of human endogenous origin. J Gen Virol. 1992 May;73(Pt 5):1087–1097. doi: 10.1099/0022-1317-73-5-1087. [DOI] [PubMed] [Google Scholar]
  45. Folks T. M., Clouse K. A., Justement J., Rabson A., Duh E., Kehrl J. H., Fauci A. S. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2365–2368. doi: 10.1073/pnas.86.7.2365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Foulds S., Wakefield C. H., Giles M., Gillespie J., Dye J. F., Guillou P. J. Expression of a suppressive p15E-related epitope in colorectal and gastric cancer. Br J Cancer. 1993 Sep;68(3):610–616. doi: 10.1038/bjc.1993.395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Franklin G. C., Chretien S., Hanson I. M., Rochefort H., May F. E., Westley B. R. Expression of human sequences related to those of mouse mammary tumor virus. J Virol. 1988 Apr;62(4):1203–1210. doi: 10.1128/jvi.62.4.1203-1210.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Gardner M. B., Chiri A., Dougherty M. F., Casagrande J., Estes J. D. Congenital transmission of murine leukemia virus from wild mice prone to the development of lymphoma and paralysis. J Natl Cancer Inst. 1979 Jan;62(1):63–70. [PubMed] [Google Scholar]
  49. Garry R. F., Fermin C. D., Hart D. J., Alexander S. S., Donehower L. A., Luo-Zhang H. Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science. 1990 Nov 23;250(4984):1127–1129. doi: 10.1126/science.1701273. [DOI] [PubMed] [Google Scholar]
  50. Gaynor R. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS. 1992 Apr;6(4):347–363. doi: 10.1097/00002030-199204000-00001. [DOI] [PubMed] [Google Scholar]
  51. Gendelman H. E., Phelps W., Feigenbaum L., Ostrove J. M., Adachi A., Howley P. M., Khoury G., Ginsberg H. S., Martin M. A. Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9759–9763. doi: 10.1073/pnas.83.24.9759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Goodchild N. L., Wilkinson D. A., Mager D. L. Recent evolutionary expansion of a subfamily of RTVL-H human endogenous retrovirus-like elements. Virology. 1993 Oct;196(2):778–788. doi: 10.1006/viro.1993.1535. [DOI] [PubMed] [Google Scholar]
  53. Gupta S., Ribak C. E., Gollapudi S., Kim C. H., Salahuddin S. Z. Detection of a human intracisternal retroviral particle associated with CD4+ T-cell deficiency. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7831–7835. doi: 10.1073/pnas.89.16.7831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Harada F., Tsukada N., Kato N. Isolation of three kinds of human endogenous retrovirus-like sequences using tRNA(Pro) as a probe. Nucleic Acids Res. 1987 Nov 25;15(22):9153–9162. doi: 10.1093/nar/15.22.9153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Haraguchi S., Good R. A., Day N. K. Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol Today. 1995 Dec;16(12):595–603. doi: 10.1016/0167-5699(95)80083-2. [DOI] [PubMed] [Google Scholar]
  56. Harbers K., Kuehn M., Delius H., Jaenisch R. Insertion of retrovirus into the first intron of alpha 1(I) collagen gene to embryonic lethal mutation in mice. Proc Natl Acad Sci U S A. 1984 Mar;81(5):1504–1508. doi: 10.1073/pnas.81.5.1504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Hartley J. W., Rowe W. P., Huebner R. J. Host-range restrictions of murine leukemia viruses in mouse embryo cell cultures. J Virol. 1970 Feb;5(2):221–225. doi: 10.1128/jvi.5.2.221-225.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Hehlmann R., Erfle V., Schetters H., Luz A., Rohmer H., Schreiber M. A., Pralle H., Essers U., Weber W. Antigens and circulating immune complexes related to the primate retroviral glycoprotein SiSVgp70. Indicators of early mortality in human acute leukemias and chronic myelogenous leukemias in blast crisis. Cancer. 1984 Dec 15;54(12):2927–2935. doi: 10.1002/1097-0142(19841215)54:12<2927::aid-cncr2820541219>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  59. Hehlmann R. RNA tumor viruses and human cancer. Curr Top Microbiol Immunol. 1976;73:141–215. doi: 10.1007/978-3-642-66306-2_5. [DOI] [PubMed] [Google Scholar]
  60. Hehlmann R., Schetters H., Erfle V., Leib-Mösch C. Detection and biochemical characterization of antigens in human leukemic sera that cross-react with primate C-type viral proteins (Mr 30,000). Cancer Res. 1983 Jan;43(1):392–399. [PubMed] [Google Scholar]
  61. Hirose Y., Takamatsu M., Harada F. Presence of env genes in members of the RTVL-H family of human endogenous retrovirus-like elements. Virology. 1993 Jan;192(1):52–61. doi: 10.1006/viro.1993.1007. [DOI] [PubMed] [Google Scholar]
  62. Hirsch M. S., Kelly A. P., Chapin D. S., Fuller T. C., Black P. H., Kurth R. Immunity to antigens associated with primate C-type oncoviruses in pregnant women. Science. 1978 Mar 24;199(4335):1337–1340. doi: 10.1126/science.204010. [DOI] [PubMed] [Google Scholar]
  63. Hizi A., Henderson L. E., Copeland T. D., Sowder R. C., Hixson C. V., Oroszlan S. Characterization of mouse mammary tumor virus gag-pro gene products and the ribosomal frameshift site by protein sequencing. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7041–7045. doi: 10.1073/pnas.84.20.7041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Horsfall A. C. Molecular mimicry and autoantigens in connective tissue diseases. Mol Biol Rep. 1992 Jun;16(3):139–147. doi: 10.1007/BF00464701. [DOI] [PubMed] [Google Scholar]
  65. Horwitz M. S., Boyce-Jacino M. T., Faras A. J. Novel human endogenous sequences related to human immunodeficiency virus type 1. J Virol. 1992 Apr;66(4):2170–2179. doi: 10.1128/jvi.66.4.2170-2179.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Hughes S. H., Toyoshima K., Bishop J. M., Varmus H. E. Organization of the endogenous proviruses of chickens: implications for origin and expression. Virology. 1981 Jan 15;108(1):189–207. doi: 10.1016/0042-6822(81)90538-9. [DOI] [PubMed] [Google Scholar]
  67. Hull R., Will H. Molecular biology of viral and nonviral retroelements. Trends Genet. 1989 Nov;5(11):357–359. doi: 10.1016/0168-9525(89)90151-0. [DOI] [PubMed] [Google Scholar]
  68. Hügin A. W., Vacchio M. S., Morse H. C., 3rd A virus-encoded "superantigen" in a retrovirus-induced immunodeficiency syndrome of mice. Science. 1991 Apr 19;252(5004):424–427. doi: 10.1126/science.1850169. [DOI] [PubMed] [Google Scholar]
  69. Imamura M., Phillips P. E., Mellors R. C. The occurrence and frequency of type C virus-like particles in placentas from patients with systemic lupus erythematosus and from normal subjects. Am J Pathol. 1976 May;83(2):383–394. [PMC free article] [PubMed] [Google Scholar]
  70. Iversen O. J. The expression of retrovirus-like particles in psoriasis. J Invest Dermatol. 1990 Nov;95(5 Suppl):41S–43S. doi: 10.1111/1523-1747.ep12505748. [DOI] [PubMed] [Google Scholar]
  71. Jacquemin P. C., Strijckmans P., Thiry L. Study of the expression of a glycoprotein of retroviral origin in the plasma of patients with hematologic disorders and in the plasma of normal individuals. Blood. 1984 Oct;64(4):832–841. [PubMed] [Google Scholar]
  72. Jeannel D., Garin B., Kazadi K., Singa L., de Thé G. The risk of tropical spastic paraparesis differs according to ethnic group among HTLV-I carriers in Inongo, Zaire. J Acquir Immune Defic Syndr. 1993 Jul;6(7):840–844. [PubMed] [Google Scholar]
  73. Jerabek L. B., Mellors R. C., Elkon K. B., Mellors J. W. Detection and immunochemical characterization of a primate type C retrovirus-related p30 protein in normal human placentas. Proc Natl Acad Sci U S A. 1984 Oct;81(20):6501–6505. doi: 10.1073/pnas.81.20.6501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Johnson P. M., Lyden T. W., Mwenda J. M. Endogenous retroviral expression in the human placenta. Am J Reprod Immunol. 1990 Aug;23(4):115–120. doi: 10.1111/j.1600-0897.1990.tb00683.x. [DOI] [PubMed] [Google Scholar]
  75. Jolicoeur P., Rassart E. Effect of Fv-1 gene product on synthesis of linear and supercoiled viral DNA in cells infected with murine leukemia virus. J Virol. 1980 Jan;33(1):183–195. doi: 10.1128/jvi.33.1.183-195.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Jones K. A., Kadonaga J. T., Luciw P. A., Tjian R. Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science. 1986 May 9;232(4751):755–759. doi: 10.1126/science.3008338. [DOI] [PubMed] [Google Scholar]
  77. Kalter S. S., Helmke R. J., Heberling R. L., Panigel M., Fowler A. K., Strickland J. E., Hellman A. Brief communication: C-type particles in normal human placentas. J Natl Cancer Inst. 1973 Apr;50(4):1081–1084. doi: 10.1093/jnci/50.4.1081. [DOI] [PubMed] [Google Scholar]
  78. Kalter S. S., Helmke R. J., Panigel M., Heberling R. L., Felsburg P. J., Axelrod L. R. Observations of apparent C-type particles in baboon (Papio cynocephalus) placentas. Science. 1973 Mar 30;179(4080):1332–1333. doi: 10.1126/science.179.4080.1332. [DOI] [PubMed] [Google Scholar]
  79. Kannan P., Buettner R., Pratt D. R., Tainsky M. A. Identification of a retinoic acid-inducible endogenous retroviral transcript in the human teratocarcinoma-derived cell line PA-1. J Virol. 1991 Nov;65(11):6343–6348. doi: 10.1128/jvi.65.11.6343-6348.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Kato N., Pfeifer-Ohlsson S., Kato M., Larsson E., Rydnert J., Ohlsson R., Cohen M. Tissue-specific expression of human provirus ERV3 mRNA in human placenta: two of the three ERV3 mRNAs contain human cellular sequences. J Virol. 1987 Jul;61(7):2182–2191. doi: 10.1128/jvi.61.7.2182-2191.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Keydar I., Ohno T., Nayak R., Sweet R., Simoni F., Weiss F., Karby S., Mesa-Tejada R., Spiegelman S. Properties of retrovirus-like particles produced by a human breast carcinoma cell line: immunological relationship with mouse mammary tumor virus proteins. Proc Natl Acad Sci U S A. 1984 Jul;81(13):4188–4192. doi: 10.1073/pnas.81.13.4188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Koyanagi Y., O'Brien W. A., Zhao J. Q., Golde D. W., Gasson J. C., Chen I. S. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science. 1988 Sep 23;241(4873):1673–1675. doi: 10.1126/science.241.4873.1673. [DOI] [PubMed] [Google Scholar]
  83. Kozak C. A. Retroviruses as chromosomal genes in the mouse. Adv Cancer Res. 1985;44:295–336. doi: 10.1016/s0065-230x(08)60030-5. [DOI] [PubMed] [Google Scholar]
  84. Krieg A. M., Gourley M. F., Perl A. Endogenous retroviruses: potential etiologic agents in autoimmunity. FASEB J. 1992 May;6(8):2537–2544. doi: 10.1096/fasebj.6.8.1592206. [DOI] [PubMed] [Google Scholar]
  85. Kröger B., Horak I. Isolation of novel human retrovirus-related sequences by hybridization to synthetic oligonucleotides complementary to the tRNA(Pro) primer-binding site. J Virol. 1987 Jul;61(7):2071–2075. doi: 10.1128/jvi.61.7.2071-2075.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Kuff E. L., Lueders K. K. The intracisternal A-particle gene family: structure and functional aspects. Adv Cancer Res. 1988;51:183–276. doi: 10.1016/s0065-230x(08)60223-7. [DOI] [PubMed] [Google Scholar]
  87. Kurth R., Teich N. M., Weiss R., Oliver R. T. Natural human antibodies reactive with primate type-C viral antigens. Proc Natl Acad Sci U S A. 1977 Mar;74(3):1237–1241. doi: 10.1073/pnas.74.3.1237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. La Mantia G., Maglione D., Pengue G., Di Cristofano A., Simeone A., Lanfrancone L., Lania L. Identification and characterization of novel human endogenous retroviral sequences prefentially expressed in undifferentiated embryonal carcinoma cells. Nucleic Acids Res. 1991 Apr 11;19(7):1513–1520. doi: 10.1093/nar/19.7.1513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Larsson E., Kato N., Cohen M. Human endogenous proviruses. Curr Top Microbiol Immunol. 1989;148:115–132. doi: 10.1007/978-3-642-74700-7_4. [DOI] [PubMed] [Google Scholar]
  90. Larsson E., Nilsson B. O., Sundström P., Widéhn S. Morphological and microbiological signs of endogenous C-virus in human oocytes. Int J Cancer. 1981 Nov 15;28(5):551–557. doi: 10.1002/ijc.2910280504. [DOI] [PubMed] [Google Scholar]
  91. Leis J., Baltimore D., Bishop J. M., Coffin J., Fleissner E., Goff S. P., Oroszlan S., Robinson H., Skalka A. M., Temin H. M. Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol. 1988 May;62(5):1808–1809. doi: 10.1128/jvi.62.5.1808-1809.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Leung K., Nabel G. J. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor. Nature. 1988 Jun 23;333(6175):776–778. doi: 10.1038/333776a0. [DOI] [PubMed] [Google Scholar]
  93. Levine P. H., Blattner W. A., Clark J., Tarone R., Maloney E. M., Murphy E. M., Gallo R. C., Robert-Guroff M., Saxinger W. C. Geographic distribution of HTLV-I and identification of a new high-risk population. Int J Cancer. 1988 Jul 15;42(1):7–12. doi: 10.1002/ijc.2910420103. [DOI] [PubMed] [Google Scholar]
  94. Loh T. P., Sievert L. L., Scott R. W. Negative regulation of retrovirus expression in embryonal carcinoma cells mediated by an intragenic domain. J Virol. 1988 Nov;62(11):4086–4095. doi: 10.1128/jvi.62.11.4086-4095.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Lusso P., di Marzo Veronese F., Ensoli B., Franchini G., Jemma C., DeRocco S. E., Kalyanaraman V. S., Gallo R. C. Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. Science. 1990 Feb 16;247(4944):848–852. doi: 10.1126/science.2305256. [DOI] [PubMed] [Google Scholar]
  96. Löwer R., Boller K., Hasenmaier B., Korbmacher C., Müller-Lantzsch N., Löwer J., Kurth R. Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4480–4484. doi: 10.1073/pnas.90.10.4480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Löwer R., Löwer J., Frank H., Harzmann R., Kurth R. Human teratocarcinomas cultured in vitro produce unique retrovirus-like viruses. J Gen Virol. 1984 May;65(Pt 5):887–898. doi: 10.1099/0022-1317-65-5-887. [DOI] [PubMed] [Google Scholar]
  98. Maeda S., Mellors R. C., Mellors J. W., Jerabek L. B., Zervoudakis I. A. Immunohistologic detection of antigen related to primate type C retrovirus p30 in normal human placentas. Am J Pathol. 1983 Sep;112(3):347–356. [PMC free article] [PubMed] [Google Scholar]
  99. Maeda S., Yonezawa K., Yoshizaki H., Mori M., Kobayashi T., Akahonai Y., Yachi A., Mellors R. C. Leukemia serum reactive with retrovirus-related antigen in normal human placenta. Int J Cancer. 1986 Sep 15;38(3):309–316. doi: 10.1002/ijc.2910380303. [DOI] [PubMed] [Google Scholar]
  100. Mager D. L., Freeman J. D. Human endogenous retroviruslike genome with type C pol sequences and gag sequences related to human T-cell lymphotropic viruses. J Virol. 1987 Dec;61(12):4060–4066. doi: 10.1128/jvi.61.12.4060-4066.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Mager D. L., Henthorn P. S. Identification of a retrovirus-like repetitive element in human DNA. Proc Natl Acad Sci U S A. 1984 Dec;81(23):7510–7514. doi: 10.1073/pnas.81.23.7510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Maniatis T., Goodbourn S., Fischer J. A. Regulation of inducible and tissue-specific gene expression. Science. 1987 Jun 5;236(4806):1237–1245. doi: 10.1126/science.3296191. [DOI] [PubMed] [Google Scholar]
  103. Martin M. A., Bryan T., Rasheed S., Khan A. S. Identification and cloning of endogenous retroviral sequences present in human DNA. Proc Natl Acad Sci U S A. 1981 Aug;78(8):4892–4896. doi: 10.1073/pnas.78.8.4892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. McMahon A. P., Bradley A. The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell. 1990 Sep 21;62(6):1073–1085. doi: 10.1016/0092-8674(90)90385-r. [DOI] [PubMed] [Google Scholar]
  105. Medstrand P., Blomberg J. Characterization of novel reverse transcriptase encoding human endogenous retroviral sequences similar to type A and type B retroviruses: differential transcription in normal human tissues. J Virol. 1993 Nov;67(11):6778–6787. doi: 10.1128/jvi.67.11.6778-6787.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Medstrand P., Lindeskog M., Blomberg J. Expression of human endogenous retroviral sequences in peripheral blood mononuclear cells of healthy individuals. J Gen Virol. 1992 Sep;73(Pt 9):2463–2466. doi: 10.1099/0022-1317-73-9-2463. [DOI] [PubMed] [Google Scholar]
  107. Mellors R. C., Mellors J. W. Type C RNA virus-specific antibody in human systemic lupus erythematosus demonstrated by enzymoimmunoassay. Proc Natl Acad Sci U S A. 1978 May;75(5):2463–2467. doi: 10.1073/pnas.75.5.2463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Mondal H., Hofschneider P. H. Isolation and characterization of retrovirus-like elements from normal human fetuses. Int J Cancer. 1982 Sep 15;30(3):281–287. doi: 10.1002/ijc.2910300305. [DOI] [PubMed] [Google Scholar]
  109. Mueller-Lantzsch N., Sauter M., Weiskircher A., Kramer K., Best B., Buck M., Grässer F. Human endogenous retroviral element K10 (HERV-K10) encodes a full-length gag homologous 73-kDa protein and a functional protease. AIDS Res Hum Retroviruses. 1993 Apr;9(4):343–350. doi: 10.1089/aid.1993.9.343. [DOI] [PubMed] [Google Scholar]
  110. Munroe D. G., Peacock J. W., Benchimol S. Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles. Mol Cell Biol. 1990 Jul;10(7):3307–3313. doi: 10.1128/mcb.10.7.3307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Murphy W. H., Nawrocki J. F., Pease L. R. Age-dependent paralytic viral infection in C58 mice: possible implications in human neurologic disease. Prog Brain Res. 1983;59:291–303. doi: 10.1016/S0079-6123(08)63874-1. [DOI] [PubMed] [Google Scholar]
  112. Méric C., Spahr P. F. Rous sarcoma virus nucleic acid-binding protein p12 is necessary for viral 70S RNA dimer formation and packaging. J Virol. 1986 Nov;60(2):450–459. doi: 10.1128/jvi.60.2.450-459.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Möstl M., Mucke H., Schinkinger M., Haushofer A., Krieger O., Lutz D. Indications for the presence of antibodies cross-reactive with HTLV-I/II, but not HIV, in patients with myelodysplastic syndrome. Clin Immunol Immunopathol. 1992 Oct;65(1):75–79. doi: 10.1016/0090-1229(92)90251-i. [DOI] [PubMed] [Google Scholar]
  114. Nabel G., Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature. 1987 Apr 16;326(6114):711–713. doi: 10.1038/326711a0. [DOI] [PubMed] [Google Scholar]
  115. Nelson J. A., Levy J. A., Leong J. C. Human placentas contain a specific inhibitor of RNA-directed DNA polymerase. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1670–1674. doi: 10.1073/pnas.78.3.1670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Nelson J. A., Reynolds-Kohler C., Oldstone M. B., Wiley C. A. HIV and HCMV coinfect brain cells in patients with AIDS. Virology. 1988 Jul;165(1):286–290. doi: 10.1016/0042-6822(88)90685-x. [DOI] [PubMed] [Google Scholar]
  117. Nilsson B. O., Kättström P. O., Sundström P., Jaquemin P., Larsson E. Human oocytes express murine retroviral equivalents. Virus Genes. 1992 Aug;6(3):221–227. doi: 10.1007/BF01702561. [DOI] [PubMed] [Google Scholar]
  118. O'Brien S. J., Bonner T. I., Cohen M., O'Connell C., Nash W. G. Mapping of an endogenous retroviral sequence to human chromosome 18. Nature. 1983 May 5;303(5912):74–77. doi: 10.1038/303074a0. [DOI] [PubMed] [Google Scholar]
  119. O'Connell C., O'Brien S., Nash W. G., Cohen M. ERV3, a full-length human endogenous provirus: chromosomal localization and evolutionary relationships. Virology. 1984 Oct 30;138(2):225–235. doi: 10.1016/0042-6822(84)90347-7. [DOI] [PubMed] [Google Scholar]
  120. Oldstone M. B. Virus neutralization and virus-induced immune complex disease. Virus-antibody union resulting in immunoprotection or immunologic injury--two sides of the same coin. Prog Med Virol. 1975;19:84–119. [PubMed] [Google Scholar]
  121. Ono M., Kawakami M., Ushikubo H. Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. J Virol. 1987 Jun;61(6):2059–2062. doi: 10.1128/jvi.61.6.2059-2062.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Ono M., Yasunaga T., Miyata T., Ushikubo H. Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. J Virol. 1986 Nov;60(2):589–598. doi: 10.1128/jvi.60.2.589-598.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Ono T., Cutler R. G. Age-dependent relaxation of gene repression: increase of endogenous murine leukemia virus-related and globin-related RNA in brain and liver of mice. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4431–4435. doi: 10.1073/pnas.75.9.4431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Panem S. C-type virus expression in the placenta. Curr Top Pathol. 1979;66:175–189. doi: 10.1007/978-3-642-67205-7_6. [DOI] [PubMed] [Google Scholar]
  125. Panem S., Ordóez N. G., Kirstein W. H., Katz A. I., Spargo B. H. C-type virus expression in systemic lupus erythematosus. N Engl J Med. 1976 Aug 26;295(9):470–475. doi: 10.1056/NEJM197608262950903. [DOI] [PubMed] [Google Scholar]
  126. Panem S., Prochownik E. V., Reale F. R., Kirsten W. H. Isolation of type C virions from a normal human fibroblast strain. Science. 1975 Jul 25;189(4199):297–299. doi: 10.1126/science.49927. [DOI] [PubMed] [Google Scholar]
  127. Pardi D., Switzer W. M., Hadlock K. G., Kaplan J. E., Lal R. B., Folks T. M. Complete nucleotide sequence of an Amerindian human T-cell lymphotropic virus type II (HTLV-II) isolate: identification of a variant HTLV-II subtype b from a Guaymi Indian. J Virol. 1993 Aug;67(8):4659–4664. doi: 10.1128/jvi.67.8.4659-4664.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Pease L. R., Murphy W. H. Co-infection by lactic dehydrogenase virus and C-type retrovirus elicits neurological disease. Nature. 1980 Jul 24;286(5771):398–400. doi: 10.1038/286398a0. [DOI] [PubMed] [Google Scholar]
  129. Perl A., Rosenblatt J. D., Chen I. S., DiVincenzo J. P., Bever R., Poiesz B. J., Abraham G. N. Detection and cloning of new HTLV-related endogenous sequences in man. Nucleic Acids Res. 1989 Sep 12;17(17):6841–6854. doi: 10.1093/nar/17.17.6841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Perron H., Lalande B., Gratacap B., Laurent A., Genoulaz O., Geny C., Mallaret M., Schuller E., Stoebner P., Seigneurin J. M. Isolation of retrovirus from patients with multiple sclerosis. Lancet. 1991 Apr 6;337(8745):862–863. doi: 10.1016/0140-6736(91)92579-q. [DOI] [PubMed] [Google Scholar]
  131. Peterlin B. M., Luciw P. A. Molecular biology of HIV. AIDS. 1988;2 (Suppl 1):S29–S40. doi: 10.1097/00002030-198800001-00005. [DOI] [PubMed] [Google Scholar]
  132. Prachar J., Vrbenská A., Hlubinová K., Simkovic D., Kovarík A. Retrovirus like particles produced by human embryonal cells and cell lines derived from human malignancies. II. Protein structure. Neoplasma. 1987;34(2):129–138. [PubMed] [Google Scholar]
  133. Ptashne M. How eukaryotic transcriptional activators work. Nature. 1988 Oct 20;335(6192):683–689. doi: 10.1038/335683a0. [DOI] [PubMed] [Google Scholar]
  134. Query C. C., Keene J. D. A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen. Cell. 1987 Oct 23;51(2):211–220. doi: 10.1016/0092-8674(87)90148-6. [DOI] [PubMed] [Google Scholar]
  135. Quinn T. C., Piot P., McCormick J. B., Feinsod F. M., Taelman H., Kapita B., Stevens W., Fauci A. S. Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection. JAMA. 1987 May 15;257(19):2617–2621. [PubMed] [Google Scholar]
  136. Rabson A. B., Steele P. E., Garon C. F., Martin M. A. mRNA transcripts related to full-length endogenous retroviral DNA in human cells. Nature. 1983 Dec 8;306(5943):604–607. doi: 10.1038/306604a0. [DOI] [PubMed] [Google Scholar]
  137. Ranki A., Kurki P., Riepponen S., Stephansson E. Antibodies to retroviral proteins in autoimmune connective tissue disease. Relation to clinical manifestations and ribonucleoprotein autoantibodies. Arthritis Rheum. 1992 Dec;35(12):1483–1491. doi: 10.1002/art.1780351212. [DOI] [PubMed] [Google Scholar]
  138. Rasmussen H. B., Perron H., Clausen J. Do endogenous retroviruses have etiological implications in inflammatory and degenerative nervous system diseases? Acta Neurol Scand. 1993 Sep;88(3):190–198. doi: 10.1111/j.1600-0404.1993.tb04215.x. [DOI] [PubMed] [Google Scholar]
  139. Repaske R., Steele P. E., O'Neill R. R., Rabson A. B., Martin M. A. Nucleotide sequence of a full-length human endogenous retroviral segment. J Virol. 1985 Jun;54(3):764–772. doi: 10.1128/jvi.54.3.764-772.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Ringold G. M. Regulation of mouse mammary tumor virus gene expression by glucocorticoid hormones. Curr Top Microbiol Immunol. 1983;106:79–103. doi: 10.1007/978-3-642-69357-1_4. [DOI] [PubMed] [Google Scholar]
  141. Robert-Guroff M., Clark J., Lanier A. P., Beckman G., Melbye M., Ebbesen P., Blattner W. A., Gallo R. C. Prevalence of HTLV-I in Arctic regions. Int J Cancer. 1985 Dec 15;36(6):651–655. doi: 10.1002/ijc.2910360605. [DOI] [PubMed] [Google Scholar]
  142. Rosenberg Z. F., Fauci A. S. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol Today. 1990 May;11(5):176–180. doi: 10.1016/0167-5699(90)90070-p. [DOI] [PubMed] [Google Scholar]
  143. Rosenthal P. N., Robinson H. L., Robinson W. S., Hanafusa T., Hanafusa H. DNA in uninfected and virus-infected cells complementary to avian tumor virus RNA. Proc Natl Acad Sci U S A. 1971 Oct;68(10):2336–2340. doi: 10.1073/pnas.68.10.2336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Ruben S., Poteat H., Tan T. H., Kawakami K., Roeder R., Haseltine W., Rosen C. A. Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product. Science. 1988 Jul 1;241(4861):89–92. doi: 10.1126/science.2838905. [DOI] [PubMed] [Google Scholar]
  145. Sato K., Maruyama I., Maruyama Y., Kitajima I., Nakajima Y., Higaki M., Yamamoto K., Miyasaka N., Osame M., Nishioka K. Arthritis in patients infected with human T lymphotropic virus type I. Clinical and immunopathologic features. Arthritis Rheum. 1991 Jun;34(6):714–721. doi: 10.1002/art.1780340612. [DOI] [PubMed] [Google Scholar]
  146. Sauter M., Schommer S., Kremmer E., Remberger K., Dölken G., Lemm I., Buck M., Best B., Neumann-Haefelin D., Mueller-Lantzsch N. Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas. J Virol. 1995 Jan;69(1):414–421. doi: 10.1128/jvi.69.1.414-421.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Segev N., Hizi A., Kirenberg F., Keydar I. Characterization of a protein, released by the T47D cell line, immunologically related to the major envelope protein of mouse mammary tumor virus. Proc Natl Acad Sci U S A. 1985 Mar;82(5):1531–1535. doi: 10.1073/pnas.82.5.1531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Shattles W. G., Brookes S. M., Venables P. J., Clark D. A., Maini R. N. Expression of antigen reactive with a monoclonal antibody to HTLV-1 P19 in salivary glands in Sjögren's syndrome. Clin Exp Immunol. 1992 Jul;89(1):46–51. doi: 10.1111/j.1365-2249.1992.tb06875.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Shih A., Coutavas E. E., Rush M. G. Evolutionary implications of primate endogenous retroviruses. Virology. 1991 Jun;182(2):495–502. doi: 10.1016/0042-6822(91)90590-8. [DOI] [PubMed] [Google Scholar]
  150. Shih A., Misra R., Rush M. G. Detection of multiple, novel reverse transcriptase coding sequences in human nucleic acids: relation to primate retroviruses. J Virol. 1989 Jan;63(1):64–75. doi: 10.1128/jvi.63.1.64-75.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Simons P. J., Oostendorp R. A., Tas M. P., Drexhage H. A. Comparison of retroviral p15E-related factors and interferon alpha in head and neck cancer. Cancer Immunol Immunother. 1994 Mar;38(3):178–184. doi: 10.1007/BF01525639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Snyder H. W., Jr, Fleissner E. Specificity of human antibodies to oncovirus glycoproteins: recognition of antigen by natural antibodies directed against carbohydrate structures. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1622–1626. doi: 10.1073/pnas.77.3.1622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Stöger H., Wilders-Truschnig M., Samonigg H., Schmid M., Bauernhofer T., Tiran A., Tas M., Drexhage H. A. The presence of immunosuppressive 'p15E-like' factors in the serum and urine of patients suffering from malign and benign breast tumours. Clin Exp Immunol. 1993 Sep;93(3):437–441. doi: 10.1111/j.1365-2249.1993.tb08197.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Suni J., Närvänen A., Wahlström T., Aho M., Pakkanen R., Vaheri A., Copeland T., Cohen M., Oroszlan S. Human placental syncytiotrophoblastic Mr 75,000 polypeptide defined by antibodies to a synthetic peptide based on a cloned human endogenous retroviral DNA sequence. Proc Natl Acad Sci U S A. 1984 Oct;81(19):6197–6201. doi: 10.1073/pnas.81.19.6197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Suni J., Wahlström T., Vaheri A. Retrovirus p30-related antigen in human syncytiotrophoblasts and IgG antibodies in cord-blood sera. Int J Cancer. 1981 Nov 15;28(5):559–566. doi: 10.1002/ijc.2910280505. [DOI] [PubMed] [Google Scholar]
  156. TEMIN H. M., RUBIN H. Characteristics of an assay for Rous sarcoma virus and Rous sarcoma cells in tissue culture. Virology. 1958 Dec;6(3):669–688. doi: 10.1016/0042-6822(58)90114-4. [DOI] [PubMed] [Google Scholar]
  157. Tadmori W., Mondal D., Tadmori I., Prakash O. Transactivation of human immunodeficiency virus type 1 long terminal repeats by cell surface tumor necrosis factor alpha. J Virol. 1991 Dec;65(12):6425–6429. doi: 10.1128/jvi.65.12.6425-6429.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Talal N., Flescher E., Dang H. Are endogenous retroviruses involved in human autoimmune disease? J Autoimmun. 1992 Apr;5 (Suppl A):61–66. doi: 10.1016/0896-8411(92)90020-q. [DOI] [PubMed] [Google Scholar]
  159. Talal N., Flescher E., Dang H. Evidence for possible retroviral involvement in autoimmune diseases. Ann Allergy. 1992 Sep;69(3):221–224. [PubMed] [Google Scholar]
  160. Tassabehji M., Strachan T., Anderson M., Campbell R. D., Collier S., Lako M. Identification of a novel family of human endogenous retroviruses and characterization of one family member, HERV-K(C4), located in the complement C4 gene cluster. Nucleic Acids Res. 1994 Dec 11;22(24):5211–5217. doi: 10.1093/nar/22.24.5211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. Temin H. M. The DNA provirus hypothesis. Science. 1976 Jun 11;192(4244):1075–1080. doi: 10.1126/science.58444. [DOI] [PubMed] [Google Scholar]
  162. Tendler C. L., Greenberg S. J., Blattner W. A., Manns A., Murphy E., Fleisher T., Hanchard B., Morgan O., Burton J. D., Nelson D. L. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc Natl Acad Sci U S A. 1990 Jul;87(13):5218–5222. doi: 10.1073/pnas.87.13.5218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Theofilopoulos A. N., Kofler R., Singer P. A., Dixon F. J. Molecular genetics of murine lupus models. Adv Immunol. 1989;46:61–109. doi: 10.1016/s0065-2776(08)60651-3. [DOI] [PubMed] [Google Scholar]
  164. Thiry L., Sprecher-Goldberger S., Hard R. C., Bossens M., Neuray F. Expression of retrovirus-related antigen in pregnancy. I. Antigens cross-reacting with simian retroviruses in human foetal tissues and cord blood lymphocytes. J Reprod Immunol. 1981 Mar;2(6):309–322. doi: 10.1016/0165-0378(81)90001-2. [DOI] [PubMed] [Google Scholar]
  165. Todaro G. J., Sherr C. J., Benveniste R. E. Baboons and their close relatives are unusual among primates in their ability to release nondefective endogenous type C viruses. Virology. 1976 Jul 1;72(1):278–282. doi: 10.1016/0042-6822(76)90331-7. [DOI] [PubMed] [Google Scholar]
  166. Urnovitz H. B., Clerici M., Shearer G. M., Gottfried T. D., Robison D. J., Lutwick L. I., Montagnier L., Landers D. V. HIV-1 antibody serum negativity with urine positivity. Lancet. 1993 Dec 11;342(8885):1458–1459. doi: 10.1016/0140-6736(93)92934-l. [DOI] [PubMed] [Google Scholar]
  167. Venables P., Brookes S. Retroviruses: potential aetiological agents in autoimmune rheumatic disease. Br J Rheumatol. 1992 Dec;31(12):841–846. doi: 10.1093/rheumatology/31.12.841. [DOI] [PubMed] [Google Scholar]
  168. Vernon M. L., McMahon J. M., Hackett J. J. Additional evidence of type-C particles in human placentas. J Natl Cancer Inst. 1974 Mar;52(3):987–989. doi: 10.1093/jnci/52.3.987. [DOI] [PubMed] [Google Scholar]
  169. Vogetseder W., Dumfahrt A., Mayersbach P., Schönitzer D., Dierich M. P. Antibodies in human sera recognizing a recombinant outer membrane protein encoded by the envelope gene of the human endogenous retrovirus K. AIDS Res Hum Retroviruses. 1993 Jul;9(7):687–694. doi: 10.1089/aid.1993.9.687. [DOI] [PubMed] [Google Scholar]
  170. Vogt P. K. A virus released by "nonproducing" Rous sarcoma cells. Proc Natl Acad Sci U S A. 1967 Sep;58(3):801–808. doi: 10.1073/pnas.58.3.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Vogt P. K. Avian tumor viruses. Adv Virus Res. 1965;11:293–385. doi: 10.1016/s0065-3527(08)60549-7. [DOI] [PubMed] [Google Scholar]
  172. Weiss R. A., Friis R. R., Katz E., Vogt P. K. Induction of avian tumor viruses in normal cells by physical and chemical carcinogens. Virology. 1971 Dec;46(3):920–938. doi: 10.1016/0042-6822(71)90091-2. [DOI] [PubMed] [Google Scholar]
  173. Werner T., Brack-Werner R., Leib-Mösch C., Backhaus H., Erfle V., Hehlmann R. S71 is a phylogenetically distinct human endogenous retroviral element with structural and sequence homology to simian sarcoma virus (SSV). Virology. 1990 Jan;174(1):225–238. doi: 10.1016/0042-6822(90)90071-x. [DOI] [PubMed] [Google Scholar]
  174. Wilkinson D. A., Freeman J. D., Goodchild N. L., Kelleher C. A., Mager D. L. Autonomous expression of RTVL-H endogenous retroviruslike elements in human cells. J Virol. 1990 May;64(5):2157–2167. doi: 10.1128/jvi.64.5.2157-2167.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Wilkinson D. A., Goodchild N. L., Saxton T. M., Wood S., Mager D. L. Evidence for a functional subclass of the RTVL-H family of human endogenous retrovirus-like sequences. J Virol. 1993 Jun;67(6):2981–2989. doi: 10.1128/jvi.67.6.2981-2989.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. Witkin S. S., Bendich A. DNA synthesizing activity in normal human sperm: location and characterization of the endogenous reaction. Exp Cell Res. 1977 Apr;106(1):47–54. doi: 10.1016/0014-4827(77)90239-7. [DOI] [PubMed] [Google Scholar]
  177. Wong-Staal F., Hahn B., Manzari V., Colombini S., Franchini G., Gelmann E. P., Gallo R. C. A survey of human leukaemias for sequences of a human retrovirus. Nature. 1983 Apr 14;302(5909):626–628. doi: 10.1038/302626a0. [DOI] [PubMed] [Google Scholar]
  178. Wong P. K. Moloney murine leukemia virus temperature-sensitive mutants: a model for retrovirus-induced neurologic disorders. Curr Top Microbiol Immunol. 1990;160:29–60. doi: 10.1007/978-3-642-75267-4_3. [DOI] [PubMed] [Google Scholar]
  179. Yamamoto K. R. Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet. 1985;19:209–252. doi: 10.1146/annurev.ge.19.120185.001233. [DOI] [PubMed] [Google Scholar]
  180. Zack J. A., Arrigo S. J., Weitsman S. R., Go A. S., Haislip A., Chen I. S. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell. 1990 Apr 20;61(2):213–222. doi: 10.1016/0092-8674(90)90802-l. [DOI] [PubMed] [Google Scholar]
  181. Zhao L. J., Giam C. Z. Interaction of the human T-cell lymphotrophic virus type I (HTLV-I) transcriptional activator Tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-I enhancer. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11445–11449. doi: 10.1073/pnas.88.24.11445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Ziegler B., Gay R. E., Huang G. Q., Fassbender H. G., Gay S. Immunohistochemical localization of HTLV-I p19- and p24-related antigens in synovial joints of patients with rheumatoid arthritis. Am J Pathol. 1989 Jul;135(1):1–5. [PMC free article] [PubMed] [Google Scholar]
  183. Závada J., Závadová Z., Russ G. Rescue of presumptive viral information from human cells by a helper oncovirus. J Gen Virol. 1986 Aug;67(Pt 8):1561–1569. doi: 10.1099/0022-1317-67-8-1561. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES